nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute myocardial infarction and acute coronary sydromes
|
|
|
2004 |
94 |
6S1 |
p. 229-241 13 p. |
artikel |
2 |
Acute myocardial infarction and acute coronary syndrome: Pharmacologic approaches
|
|
|
2004 |
94 |
6S1 |
p. 85-87 3 p. |
artikel |
3 |
Adjunctive pharmacology I
|
|
|
2004 |
94 |
6S1 |
p. 37-40 4 p. |
artikel |
4 |
Adjunctive pharmacology II
|
|
|
2004 |
94 |
6S1 |
p. 106-108 3 p. |
artikel |
5 |
Adjunct pharmacology
|
|
|
2004 |
94 |
6S1 |
p. 190-194 5 p. |
artikel |
6 |
Advances in the management of arterial, venous, and aortic disease
|
|
|
2004 |
94 |
6S1 |
p. 8-10 3 p. |
artikel |
7 |
AMI/ACS outcome markers
|
|
|
2004 |
94 |
6S1 |
p. 15-18 4 p. |
artikel |
8 |
AMI/ACS registries
|
|
|
2004 |
94 |
6S1 |
p. 11-14 4 p. |
artikel |
9 |
Angiogenesis, myogenesis and cell therapy I
|
|
|
2004 |
94 |
6S1 |
p. 19-21 3 p. |
artikel |
10 |
Angiogenesis/myogenesis cell therapy
|
|
|
2004 |
94 |
6S1 |
p. 187-189 3 p. |
artikel |
11 |
Angiogenesis/myogenesis/cell therapy II
|
|
|
2004 |
94 |
6S1 |
p. 91-93 3 p. |
artikel |
12 |
Atheroblative and thrombectomy techniques
|
|
|
2004 |
94 |
6S1 |
p. 41-44 4 p. |
artikel |
13 |
Atherosclerosis imaging: Virtual histology, remodeling and plaque rupture
|
|
|
2004 |
94 |
6S1 |
p. 115-117 3 p. |
artikel |
14 |
Bare metal stents
|
|
|
2004 |
94 |
6S1 |
p. 171-175 5 p. |
artikel |
15 |
Bifurcation lesion intervention
|
|
|
2004 |
94 |
6S1 |
p. 182-183 2 p. |
artikel |
16 |
Bifurcation lesion intervention
|
|
|
2004 |
94 |
6S1 |
p. 109-111 3 p. |
artikel |
17 |
Brachytherapy
|
|
|
2004 |
94 |
6S1 |
p. 144-147 4 p. |
artikel |
18 |
Cardiac risk factors
|
|
|
2004 |
94 |
6S1 |
p. 180-181 2 p. |
artikel |
19 |
Cardiac risk factors
|
|
|
2004 |
94 |
6S1 |
p. 100-102 3 p. |
artikel |
20 |
Carotid and neurovascular interventions
|
|
|
2004 |
94 |
6S1 |
p. 159-161 3 p. |
artikel |
21 |
Carotid intervention
|
|
|
2004 |
94 |
6S1 |
p. 61-63 3 p. |
artikel |
22 |
Carotid, subclavian & neurovascular interventions
|
|
|
2004 |
94 |
6S1 |
p. 127-129 3 p. |
artikel |
23 |
Chronic total occlusions
|
|
|
2004 |
94 |
6S1 |
p. 139-140 2 p. |
artikel |
24 |
Chronic total occlusions I
|
|
|
2004 |
94 |
6S1 |
p. 76-78 3 p. |
artikel |
25 |
Chronic total occlusions II
|
|
|
2004 |
94 |
6S1 |
p. 97-99 3 p. |
artikel |
26 |
Clinical outcomes with bare metal stents
|
|
|
2004 |
94 |
6S1 |
p. 45-48 4 p. |
artikel |
27 |
Congenital and structural heart disease
|
|
|
2004 |
94 |
6S1 |
p. 178-179 2 p. |
artikel |
28 |
Congenital & structural heart disease
|
|
|
2004 |
94 |
6S1 |
p. 30-33 4 p. |
artikel |
29 |
Contrast agents and complications
|
|
|
2004 |
94 |
6S1 |
p. 22-25 4 p. |
artikel |
30 |
Contrast agents and complications
|
|
|
2004 |
94 |
6S1 |
p. 176-177 2 p. |
artikel |
31 |
Coronary atherectomy and thrombectomy
|
|
|
2004 |
94 |
6S1 |
p. 184-186 3 p. |
artikel |
32 |
Distal protection
|
|
|
2004 |
94 |
6S1 |
p. 153-155 3 p. |
artikel |
33 |
Drug eluting stents: Comparative results
|
|
|
2004 |
94 |
6S1 |
p. 133-135 3 p. |
artikel |
34 |
Drug-eluting stents: Failures and restenosis
|
|
|
2004 |
94 |
6S1 |
p. 211-215 5 p. |
artikel |
35 |
Drug-eluting stents in diabetics & Complex patient groups
|
|
|
2004 |
94 |
6S1 |
p. 72-75 4 p. |
artikel |
36 |
Drug eluting stents: In stent restenosis
|
|
|
2004 |
94 |
6S1 |
p. 136-138 3 p. |
artikel |
37 |
Drug-eluting stents: Lesion subsets
|
|
|
2004 |
94 |
6S1 |
p. 64-67 4 p. |
artikel |
38 |
Drug eluting stents: Long term results
|
|
|
2004 |
94 |
6S1 |
p. 130-132 3 p. |
artikel |
39 |
Drug-eluting stents: Miscellaneous
|
|
|
2004 |
94 |
6S1 |
p. 223-228 6 p. |
artikel |
40 |
Drug-eluting stents: Patient and lesion subsets
|
|
|
2004 |
94 |
6S1 |
p. 216-222 7 p. |
artikel |
41 |
Drug-eluting stents: Registries and trials
|
|
|
2004 |
94 |
6S1 |
p. 68-71 4 p. |
artikel |
42 |
Drug-eluting stents: Registries and trials
|
|
|
2004 |
94 |
6S1 |
p. 206-210 5 p. |
artikel |
43 |
Endovascular interventions
|
|
|
2004 |
94 |
6S1 |
p. 166-170 5 p. |
artikel |
44 |
Imaging and physiologic assessment
|
|
|
2004 |
94 |
6S1 |
p. 162-165 4 p. |
artikel |
45 |
Imaging techniques
|
|
|
2004 |
94 |
6S1 |
p. 118-120 3 p. |
artikel |
46 |
In-stent restenosis
|
|
|
2004 |
94 |
6S1 |
p. 151-152 2 p. |
artikel |
47 |
Left main intervention
|
|
|
2004 |
94 |
6S1 |
p. 1-4 4 p. |
artikel |
48 |
Miscellaneous
|
|
|
2004 |
94 |
6S1 |
p. 195-205 11 p. |
artikel |
49 |
MRI/CT in coronary artery disease
|
|
|
2004 |
94 |
6S1 |
p. 52-54 3 p. |
artikel |
50 |
Novel approaches to limit reperfusion injury & LV remodeling
|
|
|
2004 |
94 |
6S1 |
p. 88-90 3 p. |
artikel |
51 |
Novel imaging & device approaches
|
|
|
2004 |
94 |
6S1 |
p. 94-96 3 p. |
artikel |
52 |
Novel intervention for peripheral arterial disease
|
|
|
2004 |
94 |
6S1 |
p. 5-7 3 p. |
artikel |
53 |
Outcome & prevention of peri-procedure MI after stent implantation
|
|
|
2004 |
94 |
6S1 |
p. 112-114 3 p. |
artikel |
54 |
Physiolic lesion assessment
|
|
|
2004 |
94 |
6S1 |
p. 49-51 3 p. |
artikel |
55 |
Renal and mesenteric artery intervention: Optimizing outcomes
|
|
|
2004 |
94 |
6S1 |
p. 82-84 3 p. |
artikel |
56 |
Stent design and technologies
|
|
|
2004 |
94 |
6S1 |
p. 156-158 3 p. |
artikel |
57 |
Stent design and technologies
|
|
|
2004 |
94 |
6S1 |
p. 26-29 4 p. |
artikel |
58 |
Thrombectomy and distal protection I
|
|
|
2004 |
94 |
6S1 |
p. 34-36 3 p. |
artikel |
59 |
Thrombectomy and distal protection II
|
|
|
2004 |
94 |
6S1 |
p. 103-105 3 p. |
artikel |
60 |
Treatment of in-stent restenosis
|
|
|
2004 |
94 |
6S1 |
p. 55-57 3 p. |
artikel |
61 |
Valve intervention
|
|
|
2004 |
94 |
6S1 |
p. 79-81 3 p. |
artikel |
62 |
Vascular access
|
|
|
2004 |
94 |
6S1 |
p. 148-150 3 p. |
artikel |
63 |
Vascular access and complications I
|
|
|
2004 |
94 |
6S1 |
p. 58-60 3 p. |
artikel |
64 |
Vascular access and complications II
|
|
|
2004 |
94 |
6S1 |
p. 124-126 3 p. |
artikel |
65 |
Vulnerable plaque
|
|
|
2004 |
94 |
6S1 |
p. 141-143 3 p. |
artikel |
66 |
Vulnerable plaque
|
|
|
2004 |
94 |
6S1 |
p. 121-123 3 p. |
artikel |